Related Experiment Videos
Plasma somatostatin levels in ulcerative colitis
11st Department of Internal Medicine, Comenius University, Bratislava, Slovak Republic.
Hepato-Gastroenterology
|December 1, 1994
Summary
Ulcerative colitis (UC) patients exhibit altered circadian rhythms of somatostatin, with higher levels and prolonged peak phases. This suggests somatostatin may play a protective role in inflammatory bowel disease.
Area of Science:
- Endocrinology
- Gastroenterology
- Chronobiology
Background:
- Circadian rhythms regulate numerous physiological processes.
- Somatostatin is a peptide hormone with diverse biological functions.
- Inflammatory bowel disease (IBD), including ulcerative colitis (UC), involves complex pathophysiological mechanisms.
Purpose of the Study:
- To investigate and establish the 24-hour rhythmicity of somatostatin in healthy individuals.
- To compare the circadian rhythm of somatostatin in patients with ulcerative colitis (UC) to that of healthy subjects.
- To explore the potential role of somatostatin in the context of inflammatory bowel disease.
Main Methods:
- Blood samples were collected from healthy subjects and UC patients over a 24-hour period.
- Plasma somatostatin levels were measured at regular intervals.
- Circadian parameters, including amplitude, average level, and peak phase, were analyzed.
Main Results:
- Healthy subjects exhibited a defined circadian rhythm of somatostatin.
- UC patients demonstrated a significantly higher 24-hour amplitude of plasma somatostatin compared to controls.
- Patients with UC also showed higher average plasma somatostatin levels and a longer peak level phase.
Conclusions:
- The circadian rhythm of somatostatin is altered in patients with ulcerative colitis.
- Elevated somatostatin levels and prolonged peak phases in UC suggest a potential compensatory or defensive mechanism.
- Somatostatin may have a role in modulating the inflammatory processes associated with inflammatory bowel disease.